Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Riluzole inhibits spontaneous Ca2+ signaling in neuroendocrine cells by activation of K+ channels and inhibition of Na+ channels.
Is natalizumab overshooting its rebound?
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
Efficient transdifferentiation of human adipose-derived stem cells into Schwann-like cells: A promise for treatment of demyelinating diseases.
Health-related quality of life and disease-modifying treatment behaviour in relapsing-remitting multiple sclerosis - a multicentre cohort study.
160 Surgical outcomes of trigeminal neuralgia in patients with multiple sclerosis.
Spinal Cord Atrophy and Early Motor Recovery following Transverse Myelitis in Pediatric Patients.
No excess of mitochondrial DNA deletions within muscle in progressive multiple sclerosis.
Young Researchers in Life Sciences Meeting 2012
Accelerated repair of demyelinated CNS lesions in the absence of non-muscle myosin IIB.
Neuromyelitis optica: clinical manifestations and neuroimaging features.
SIGLEC1 and SIGLEC7 expression in circulating monocytes of patients with multiple sclerosis.
Rebound of disease activity during pregnancy after withdrawal of fingolimod.
In multiple sclerosis oligoclonal bands connect to peripheral B cell responses.
Reversible cerebral vasoconstriction syndrome associated with fingolimod treatment in relapsing-remitting multiple sclerosis three months after childbirth.
Autophagic myelin destruction by schwann cells during wallerian degeneration and segmental demyelination.
Assessing upper limb function in multiple sclerosis.
Central and Peripheral Nervous System Demyelination Following Mycoplasma Pneumonia Infection With Review of Literature.
Neuropsychological Aspects of Childhood Multiple Sclerosis: An Overview.
The VZV/IE63-specific T cell response prevents herpes zoster in fingolimod-treated patients.
Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells.
FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination.
FDA approves first oral drug to reduce MS relapses
HLA-DRB1-DQB1 Haplotypes Confer Susceptibility and Resistance to Multiple Sclerosis in Sardinia.
Comparison of a 1.5T standard vs. 3T optimized protocols in multiple sclerosis patients.

Pages